Compounds > parthenolide

parthenolide and Colonic Neoplasms

parthenolide has been researched along with Colonic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Chen, Y; Ding, Y; Ge, W; Guo, H; Li, S; Wang, M; Zhang, Q1
Kim, SL; Kim, SW; Lee, ST; Park, YR1
Bosia, A; Doublier, S; Ghigo, D; Miraglia, E; Pescarmona, G; Riganti, C; Viarisio, D1
Pajak, B1

Reviews

1 review(s) available for parthenolide and Colonic Neoplasms

ArticleYear
Antiapoptotic proteins as targets for bioactive compounds.
    Polish journal of veterinary sciences, 2007, Volume: 10, Issue:2

    Topics: Butyrates; Colonic Neoplasms; Fatty Acids; Humans; Immunotherapy; Phytotherapy; Sesquiterpenes; Tanacetum parthenium

2007

Other Studies

3 other study(ies) available for parthenolide and Colonic Neoplasms

ArticleYear
Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
    European journal of medicinal chemistry, 2018, Aug-05, Volume: 156

    Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Proliferation; Click Chemistry; Colonic Neoplasms; Copper; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Nanoparticles; Oxides; Sesquiterpenes; Triazoles

2018
Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    International journal of oncology, 2017, Volume: 51, Issue:6

    Topics: Animals; Cell Hypoxia; Colonic Neoplasms; Down-Regulation; Epithelial-Mesenchymal Transition; Female; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays

2017
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.
    British journal of pharmacology, 2009, Volume: 156, Issue:7

    Topics: Antimalarials; Antimetabolites, Antineoplastic; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phosphorylation; Protein Transport; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sesquiterpenes

2009